ANZ News
The AI co-developed with ASX-listed Artrya can outperform the Agatston score in predicting cardiac events.
Also, NSW Health launches its latest virtual menopause health hub in southwestern Sydney.
Proceeds will go to settling debts and focusing on its business in the United States.
Also, new mobile applications promoting mental wellbeing have been launched.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.
Trained on two million skin images, it can perform a range of clinical tasks unlike current models.
It has shown potential to significantly reduce pain intensity.
This innovative approach, devised by the National Centre for Healthy Ageing, is expected to identify more people with dementia early.
Also, The Clinician's patient-reported measures platform is coming to Magentus' marketplace.